Viewing Study NCT00934895


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2026-02-01 @ 5:36 PM
Study NCT ID: NCT00934895
Status: TERMINATED
Last Update Posted: 2023-09-18
First Post: 2009-07-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Sponsor: Rutgers, The State University of New Jersey
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View
None stage IV breast cancer View
None HER2-negative breast cancer View
None recurrent breast cancer View